Theriva Biologics (TOVX) EPS (2013 - 2026)
Theriva Biologics (TOVX) EPS from Mar 31, 2013 to Mar 31, 2026. The TTM Theriva Biologics (TOVX) EPS is -$1.97. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Theriva Biologics (TOVX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -37.65% |
| 3 Years TTM | -6.86% |
| 5 Years TTM | -20.09% |
| 10 Years TTM | -34.00% |
| All Time TTM | -25.52% |
Annual EPS change of Theriva Biologics (TOVX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.04 | -93.32% |
| 2025 | -$0.67 | -58.41% |
| 2024 | -$1.60 | +7.64% |
| 2023 | -$1.49 | -37.20% |
| 2022 | -$2.37 | -12.38% |
| 2021 | -$2.70 | -59.96% |
| 2020 | -$6.74 | +2.75% |
| 2019 | -$6.56 | -65.38% |
| 2018 | -$18.96 | -36.92% |
| 2017 | -$30.05 | -58.96% |
| 2016 | -$73.23 | -46.87% |
| 2015 | -$137.83 | +73.88% |
| 2014 | -$79.27 | +24.89% |
| 2013 | -$63.47 | N/A |
Comparison Theriva Biologics (TOVX) five years EPS CAGR with competitors
Theriva Biologics (TOVX) five years EPS CAGR is -21.74%.